TSX open
Loading markets…

Advertisement

Stocks

What's Going On With Apotex Health Corp Stock Thursday?

By Wealth Awesome -

Follow live quotes and coverage.

Stocks & ETFs:APTX.TO

Follow APTX

Photos provided by Pexels

Apotex Health Corp sees a modest uptick in stock performance this week amid significant corporate developments.

This week, Apotex Health Corp (APTX.TO) has experienced a positive price movement, reflecting a 2.34% increase over the past week and a notable year-to-date rise of 22.36%. Today's closing price stands at C$33.30, up 1.94% from the previous day. The catalyst for this week’s performance appears to be the recent announcement regarding the closing of an upsized bought deal secondary offering.

Advertisement

Apotex Health Corp

APTX.TO

Full stock page →

APTX.TO

Apotex Health Corp

Source:WealthAwesomeWealthAwesome
$6.15 (22.36%)
72 day period
$27.50$33.59$39.67Jun 11Aug 4Sep 23

Market cap

$7.54B

52W high

$40.11

52W low

$26.01

1W change

+2.34%

Analyst Price Targets

Based on analyst covering APTX · as of Sep 23, 2026

📈

Wall Street analysts forecast APTX stock price to rise 22.9% over the next 12 months.

Consensus

Bullish

Based on avg. target vs last close (formal rating unavailable for Canadian listings)

Avg. Target

C$41.37

+22.9% Upside

Previously C$41.23 on Sep 17, 2026

Current Price

C$33.65

Last close

Compare analyst targets →

Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.

Wealth Awesome Price Forecast

WA Model

Statistical 90-day price range based on APTX's historical volatility

HistoricalForecast68%95%
C$18.80C$27.12C$35.44C$43.76C$52.08C$60.40TodayJun 11Aug 4Sep 23Nov 5Dec 19Jan 31

30-Day Vol

46.3%

Annualized

90-Day Vol

49.6%

Annualized

Trend (90d)

+0.5%

Annualized drift

90d Mean

C$33.71

Expected price

HorizonExpected68% Range (1σ)
30 trading daysC$33.67C$28.70C$39.50
60 trading daysC$33.69C$26.88C$42.23
90 trading daysC$33.71C$25.56C$44.46

Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.

Advertisement

Investor takeaway: Investors should consider the implications of Apotex's recent capital-raising efforts alongside the technical indicators that suggest mixed signals regarding the stock's immediate price trajectory.

C$33.30 closing price reflects a 1.94% increase today.

With a market cap of approximately C$7.54 billion, Apotex's stock is currently trading within 52% of its 52-week range, indicating potential volatility.

Bull case

The completion of the secondary offering could give Apotex a financial boost, enhancing its growth prospects and operational flexibility. This might attract long-term investors looking for potential in the company.

Bear case

Despite raising capital, Apotex still faces challenges with profitability, as shown by its negative profit margin and earnings per share. This situation may deter risk-averse investors from considering the stock.

Recent Company News

Advertisement

On September 18, 2026, Apotex Health Corp announced the successful closing of an upsized bought deal secondary offering. This move is designed to strengthen the company's financial position by raising additional capital, which could be utilized for various operational purposes.

Technical Picture

Currently, Apotex Health Corp's stock is trading at C$33.30, which is 5.6% below its 50-day moving average of C$35.27 and 2.5% below the 200-day moving average of C$34.16. The stock has shown a 52-week range between C$26.01 and C$40.11, indicating it is currently at 52% of its range. The recent trading volume of 82,045 shares is notably higher than the 20-day average volume of 666,295 shares, suggesting increased investor interest.

Insider Activity

No recent insider activity has been reported for Apotex Health Corp, indicating that there have not been any significant transactions by executives or board members that could influence investor sentiment.


Advertisement

Wealth Awesome
Written by

Wealth Awesome

Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.

View Full Profile →

✅ Reviewed by Certified Financial Professionals

This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.

Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.

📊 Data AccuracyVerified sources
🇨🇦 Canadian FocusLocal expertise
🔍 Fact-CheckedEditorial review

⚠️ Professional Disclaimer

This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.

Published: September 24, 2026
Last Updated: September 24, 2026

Core portfolio

Awesome Portfolio™

15.1% a year since 2017, against 9.9% for the S&P/TSX Composite. Ten stocks, easy to manage. We update it once a month.

Annualized

+15.1%

Awesome Portfolio™

+9.9%

S&P/TSX

+5.2 pp better a year

Total return

+260%

Awesome Portfolio™

+137%

S&P/TSX

+123 pp better than the TSX

2017-07-31 to 2026-09-17, dividends reinvested, before fees and tax.

Awesome Portfolio™S&P/TSX CompositeCumulative return · 2017-07-31–2026-09-17
-11.7%42.8%97.2%151.6%206.0%260.4%Jul 17Oct 19Feb 22Jun 24Sep 26

Sponsored links

Advertisement